2-[2-(Trifluoromethyl)-1H-1,3-benzodiazol-1-yl]-N-[3-(trifluoromethyl)phenyl]propanamide

Catalog No. :
ACIJRW346
CAS No. :
478080-07-8
Molecular Formula :
C18H13F6N3O
Molecular Weight :
401.31

IUPAC Name:2-(2-(trifluoromethyl)-1H-benzo[d]imidazol-1-yl)-N-(3-(trifluoromethyl)phenyl)propanamide

2-[2-(Trifluoromethyl)-1H-1,3-benzodiazol-1-yl]-N-[3-(trifluoromethyl)phenyl]propanamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-[2-(Trifluoromethyl)-1H-1,3-benzodiazol-1-yl]-N-[3-(trifluoromethyl)phenyl]propanamide
IUPAC Name2-(2-(trifluoromethyl)-1H-benzo[d]imidazol-1-yl)-N-(3-(trifluoromethyl)phenyl)propanamide
MDL No.MFCD02571610
Molecular FormulaC18H13F6N3O
Molecular Weight401.31
SMILESCC(N1C(C(F)(F)F)=NC2=CC=CC=C21)C(NC3=CC=CC(C(F)(F)F)=C3)=O
InChI KeyADDBGKDAWPWZJL-UHFFFAOYSA-N
Synonym2-[2-(TRIFLUOROMETHYL)-1H-1,3-BENZIMIDAZOL-1-YL]-N-[3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE;2-[2-(trifluoromethyl)-1H-1,3-benzodiazol-1-yl]-N-[3-(trifluoromethyl)phenyl]propanamide;1H-Benzimidazole-1-acetamide, α-methyl-2-(trifluoromethyl)-N-[3-(trifluoromethyl)phenyl]-
CAS No.478080-07-8

Synthetic Route by SureRoute

1. ACIJRW346 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRAUC529 route compound structure diagram
    ACRAUC5292646-97-1 In Stock
  4. Then
  5. ACIJRW346 route product structure diagram
    ACIJRW346478080-07-8
Inquiry

2. ACIJRW346 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPSRI805 route compound structure diagram
    ACPSRI805312-73-2 In Stock
  4. Then
  5. ACIJRW346 route product structure diagram
    ACIJRW346478080-07-8
Inquiry

Comments (0)